- Investing Ideas
- Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Vitrolife
Market Cap: SEK 12.3b
Vitrolife AB (publ) suministra productos de reproducción asistida en Europa, Oriente Medio, África, Asia-Pacífico y América.
New
VITR
SEK 91.05
7D
3.0%
1Y
-34.3%
BioGaia
Market Cap: SEK 11.7b
BioGaia AB (publ), empresa del sector sanitario, suministra productos probióticos en todo el mundo.
BIOG B
SEK 115.90
7D
0.6%
1Y
17.3%